Skip to Content

Targeted Therapy for Neurofibromatosis Type-2 Mutated Vestibular Schwannomas

Neurofibromatosis-type 2 Mutated Vestibular Schwannomas is a rare genetic disorder that causes noncancerous tumors to grow on the auditory nerves, leading to hearing loss, tinnitus, and balance issues. In this MEDtalk, Shivani Chiranth from the Department for Cancer Treatment at DCCC Brain Tumor Center, Rigshospitalet in Denmark, presents the results of a systematic review that investigated the effectiveness and potential side effects of bevacizumab in treating patients with this condition.

Shivani Bangalore Chiranth

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top